Trial intelligence / Profile preview

Heliox versus air during exercise retraining in severe chronic obstructive pulmonary disease

2009-010621-39Phase 2Active

Sponsor
Comité Départemental d'Hygiène Sociale
Start
May 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of heliox in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Comité Départemental d'Hygiène Sociale. Primary endpoint: Change in endurance exercise duration on cycle ergometer. Started May 2009; status: active.

02

Drugs

heliox
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on 2009-010621-39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-010621-39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call